← Back to all stories
In a Promising First, Common Medication Shown to Help Slow Biological Aging Markers
Photo: Towfiqu barbhuiya / Unsplash
A new study has revealed that semaglutide, the active ingredient in Ozempic, can reduce markers of biological aging in adults living with HIV. This discovery represents the first clinical evidence of the drug's potential anti-aging benefits, opening up encouraging new possibilities for long-term health and wellness.
A new study has revealed that semaglutide, the active ingredient in Ozempic, can reduce markers of biological aging in adults living with HIV. This discovery represents the first clinical evidence of the drug’s potential anti-aging benefits, opening up encouraging new possibilities for long-term health and wellness.